Pfizer Has A Head Start, But The Covid-19 Vaccine Market Is Still Up For Grabs

(November 14 05:40) Forbes.com Business

Any first-mover advantage won’t last long, as some vaccine candidates may be easier to transport and administer than others.

You can find the original article here